← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #759 OF 1,000 MOST-CITED

Contamination of passenger stations

FDA cited this observation 26 times across 23 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Parts 1240 and 125026
BY FISCAL YEAR
FY20263
FY20256
FY20232
FY20222
FY20201
FY20194
FY20181
FY20171
FY20166

How FDA worded it — real examples

Failure to dispose of human wastes in such a manner as to avoid contamination of passenger.

Circle Line Sightseeing Yachts Inc · New York, New York · Parts 1240 and 1250 · 2026-06-29

Failure to dispose of human wastes in such a manner as to avoid contamination of passenger areas and stations.

LaGuardia Gateway Partners, LLC · Flushing, New York · Parts 1240 and 1250 · 2026-03-09

Failure to dispose of human wastes in such a manner as to avoid contamination of passenger areas and stations.

American Airlines, Inc. · Flushing, New York · Parts 1240 and 1250 · 2025-12-12

Failure to dispose of human wastes in such a manner as to avoid contamination of passenger areas and stations.

HornBlower Cruises and Events LLC · New York, New York · Parts 1240 and 1250 · 2025-09-30

Failure to dispose of human wastes in such a manner as to avoid contamination of passenger stations.

Seastreak LLC · Belford, New Jersey · Parts 1240 and 1250 · 2025-09-04

Failure to dispose of human wastes in such a manner as to avoid contamination of passenger areas and stations.

JFK International Air Terminal LLC · Jamaica, New York · Parts 1240 and 1250 · 2025-07-14

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Contamination control

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →